Literature DB >> 3348042

[Viral nucleic acids in the serum of hepatitis B patients].

H Hofmann1, W Tuma, F X Heinz, C Kunz.   

Abstract

Detection of hepatitis B viral DNA (HBV-DNA) is the most reliable test for infectivity of a patient's serum. HBV-DNA was detected by spot hybridization on nylon membrane. HBV-DNA was detected during the first or second week of jaundice in 22/133 (16.5%) sera from patients with acute hepatitis who did not develop chronic disease later on. However, in patients with acute hepatitis who later on developed the chronic form, HBV-DNA was found in 12/12 (100%) cases in the first or second week after onset. In other patients who had chronic hepatitis for longer than one year HBV-DNA was detected in 92/113 (81.4%) sera when HBe antigen was also detectable and in 11/104 (10.6%) when HBe antibodies were found. HBV-DNA was present in 32/38 (84.2%) sera from healthy antigen carriers when HBe antigen was detected and only in 2/173 (1.2%) sera of HBe antibody positive HBs antigen carriers. The highest levels of HBV-DNA were found in patients with chronic hepatitis B infection who were found in patients with chronic hepatitis B infection who were on haemodialysis therapy. Almost all had HBe antigen and HBV-DNA was also detectable in 82/84 (97%) sera. 11/28 (39.3%) sera from patients with chronic hepatitis B as well as HIV infection showed HBV-DNA. Detection of HBV-DNA has significantly improved the accuracy of diagnosis of hepatitis B viral infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348042

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  2 in total

1.  Infectivity of medical staff for hepatitis B.

Authors:  H Hofmann; W Tuma; F X Heinz; W Frisch-Niggemeyer; C Kunz
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

Review 2.  Molecular hybridization techniques in current diagnosis of chronic hepatitis B in childhood.

Authors:  S Wirth; B Zabel
Journal:  Eur J Pediatr       Date:  1992-04       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.